Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma
Condition(s):Hepatocellular CarcinomaLast Updated:June 28, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Hepatocellular CarcinomaLast Updated:June 28, 2023Recruiting
Condition(s):Hepatocellular Carcinoma; CirrhosisLast Updated:June 18, 2023Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:March 5, 2024Recruiting
Condition(s):Cirrhosis, Liver; Liver Fibrosis; Ascites HepaticLast Updated:March 19, 2024Recruiting
Condition(s):Portosystemic Collateral VeinsLast Updated:September 4, 2020Not yet recruiting
Condition(s):Asymptomatic Cirrhosis; Clinically Significant Portal HypertensionLast Updated:February 20, 2024Not yet recruiting
Condition(s):Healthy; Liver DiseasesLast Updated:March 25, 2024Recruiting
Condition(s):Hepatocellular Carcinoma by BCLC StageLast Updated:November 9, 2023Recruiting
Condition(s):Hepatocellular CarcinomaLast Updated:March 21, 2023Recruiting
Condition(s):Acute-On-Chronic Liver FailureLast Updated:November 22, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.